Review



mouse anti tfpi 2 monoclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    R&D Systems mouse anti tfpi 2 monoclonal antibody
    Mouse Anti Tfpi 2 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/Human+TFPI-2+Antibody/pm30258071-138-0-17
    Average 88 stars, based on 1 article reviews
    mouse anti tfpi 2 monoclonal antibody - by Bioz Stars, 2026-09
    88/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9
    Article Snippet: .. Mouse anti-TFPI-2 monoclonal antibody (MAB2545) and goat polyclonal antibody (AF2545) against human recombinant TFPI-2 were purchased from R&D systems (Minneapolis, MN, USA). .. Mouse anti-hTFPI-2 monoclonal antibody (sc-483800) was purchased from Santa Cruz Biotechnology, Inc. (Dallas, USA).

    Article Title: TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.
    Article Snippet: .. Mouse anti-TFPI-2 monoclonal antibody (MAB2545) and goat polyclonal antibody (AF2545) against human recombinant TFPI-2 were purchased from R&D systems (Minneapolis, MN, USA). .. Mouse anti-hTFPI-2 monoclonal antibody (sc-483800) was purchased from Santa Cruz Biotechnology, Inc. (Dallas, USA).



    Similar Products

    human tfpi-2 antibody  (Bio-Techne corporation)
    90
    Bio-Techne corporation human tfpi-2 antibody
    Human Tfpi 2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/Human+TFPI-2+Antibody/bio-techne+corporation___mab2545
    Average 90 stars, based on 1 article reviews
    human tfpi-2 antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal anti tfpi2 antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse monoclonal anti tfpi2 antibody
    Comparison of serum <t>TFPI2</t> levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2
    Mouse Monoclonal Anti Tfpi2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/TFPI-2+Antibody/pmc11351603-109-9-16
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti tfpi2 antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mouse anti tfpi 2 monoclonal antibody  (R&D Systems)
    88
    R&D Systems mouse anti tfpi 2 monoclonal antibody
    Comparison of serum <t>TFPI2</t> levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2
    Mouse Anti Tfpi 2 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/Human+TFPI-2+Antibody/pm30258071-138-0-17
    Average 88 stars, based on 1 article reviews
    mouse anti tfpi 2 monoclonal antibody - by Bioz Stars, 2026-09
    88/100 stars
    		  Buy from Supplier
    monoclonal mouse anti-human tfpi directed against the kunitz domain 2  (Sanquin)
    90
    Sanquin monoclonal mouse anti-human tfpi directed against the kunitz domain 2
    Comparison of serum <t>TFPI2</t> levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2
    Monoclonal Mouse Anti Human Tfpi Directed Against The Kunitz Domain 2, supplied by Sanquin, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/monoclonal+antibodies+against+tfpi/pm27977318-61-38-41
    Average 90 stars, based on 1 article reviews
    monoclonal mouse anti-human tfpi directed against the kunitz domain 2 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    monoclonal anti tfpi 2  (R&D Systems)
    90
    R&D Systems monoclonal anti tfpi 2
    Comparison of serum <t>TFPI2</t> levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2
    Monoclonal Anti Tfpi 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/Mouse+TFPI-2+Antibody/10__1042_slash_bj20110533-61-16-18
    Average 90 stars, based on 1 article reviews
    monoclonal anti tfpi 2 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    immunohistochemical staining against mouse anti tfpi2 monoclonal antibody  (R&D Systems)
    90
    R&D Systems immunohistochemical staining against mouse anti tfpi2 monoclonal antibody
    Comparison of serum <t>TFPI2</t> levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2
    Immunohistochemical Staining Against Mouse Anti Tfpi2 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+tfpi+2+monoclonal+antibody/Mouse+TFPI-2+Antibody/pm19195878-74-0-8
    Average 90 stars, based on 1 article reviews
    immunohistochemical staining against mouse anti tfpi2 monoclonal antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of serum TFPI2 levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Comparison of serum TFPI2 levels between healthy controls and patients with endometrial cancer. The Mann–Whitney U test showed that the serum TFPI2 levels of patients with endometrial cancer were significantly higher than those of healthy controls (median 196.7 pg/mL vs. 83.3 pg/mL). *** indicates p < 0.001. The dotted line indicates 191 pg/mL. TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques: Comparison, MANN-WHITNEY

    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques:

    Serum TFPI2 levels of patients with endometrial cancer by histological types and FIGO stages. ( A ) TFPI2 levels were significantly higher in the high-risk group than in the low-risk group (220.8 pg/mL vs. 187.7 pg/mL, p < 0.001). ( B ) TFPI2 levels were significantly higher in stage III and IV than in stage I (stage I, 189.6 pg/mL; stage III, 230.9 pg/mL; stage IV, 312.5 pg/mL). *** indicates p < 0.001 in the Mann–Whitney U test. The dotted line indicates 191 pg/mL. CS, carcinosarcoma; EMG, endometrioid carcinoma grade; FIGO, International Federation of Gynecology and Obstetrics; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Serum TFPI2 levels of patients with endometrial cancer by histological types and FIGO stages. ( A ) TFPI2 levels were significantly higher in the high-risk group than in the low-risk group (220.8 pg/mL vs. 187.7 pg/mL, p < 0.001). ( B ) TFPI2 levels were significantly higher in stage III and IV than in stage I (stage I, 189.6 pg/mL; stage III, 230.9 pg/mL; stage IV, 312.5 pg/mL). *** indicates p < 0.001 in the Mann–Whitney U test. The dotted line indicates 191 pg/mL. CS, carcinosarcoma; EMG, endometrioid carcinoma grade; FIGO, International Federation of Gynecology and Obstetrics; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques: MANN-WHITNEY

    Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques:

    Kaplan–Meier curve of preoperative serum TFPI2 levels and 5-year survival. Serum TFPI2 positivity is associated with poor prognosis in patients with endometrial cancer. P-value was calculated using the log-rank test (HR, 8.22; 95% CI, 2.49–27.1; p < 0.001). CI, confidence interval; HR, hazard ratio; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Kaplan–Meier curve of preoperative serum TFPI2 levels and 5-year survival. Serum TFPI2 positivity is associated with poor prognosis in patients with endometrial cancer. P-value was calculated using the log-rank test (HR, 8.22; 95% CI, 2.49–27.1; p < 0.001). CI, confidence interval; HR, hazard ratio; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques:

    Multivariate analysis of prognostic factors for overall survival

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Multivariate analysis of prognostic factors for overall survival

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques:

    Microscopic immunohistochemistry images of TFPI2 expression in endometrial cancer tissues. Microscopic images show immunohistochemistry for TFPI2 in ( A ) clear cell carcinoma with intensity 0, ( B ) endometrioid carcinoma grade 3 with intensity 1+, ( C ) clear cell carcinoma with intensity 2+, and ( D ) serous carcinoma with intensity 3+. There were both IHC-positive and IHC-negative cases for all histological types. HE, hematoxylin eosin; IHC, immunohistochemistry; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Microscopic immunohistochemistry images of TFPI2 expression in endometrial cancer tissues. Microscopic images show immunohistochemistry for TFPI2 in ( A ) clear cell carcinoma with intensity 0, ( B ) endometrioid carcinoma grade 3 with intensity 1+, ( C ) clear cell carcinoma with intensity 2+, and ( D ) serous carcinoma with intensity 3+. There were both IHC-positive and IHC-negative cases for all histological types. HE, hematoxylin eosin; IHC, immunohistochemistry; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques: Immunohistochemistry, Expressing

    Boxplots of IHC scores by each histological type. The Mann–Whitney U test showed no significant differences in IHC scores among histological types ( p = 0.427). CS, carcinosarcoma; EMG, endometrioid carcinoma grade; IHC, immunohistochemistry; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Boxplots of IHC scores by each histological type. The Mann–Whitney U test showed no significant differences in IHC scores among histological types ( p = 0.427). CS, carcinosarcoma; EMG, endometrioid carcinoma grade; IHC, immunohistochemistry; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: Immunohistochemistry (IHC) was performed using the same concentration of mouse monoclonal anti-TFPI2 antibody (sc-48380, diluted 1:200, Santa Cruz Biotechnology, Inc., CA, USA) as the primary antibody to ensure consistency of our experimental approach [ ].

    Techniques: MANN-WHITNEY, Immunohistochemistry